US Diagnostic and Laboratory Equipment Stocks Surge 15% Post Earnings Release

Agilent Technologies Inc. (Ticker: A) surged 15.13% on the New York Stock Exchange on the 27th, closing at $132.49.

Its market capitalization climbed to approximately $37.4 billion (about KRW 48.7 trillion), adding roughly $6.67 billion (around KRW 8.7 trillion) in a single day.

The company reported second-quarter net income of $339 million (approximately KRW 440 billion) and raised its full-year guidance to earnings per share of $6.00–6.10 and revenue of around $7.4 billion (about KRW 9.7 trillion), bolstering expectations of continued momentum.

On the same day, RBC Capital reaffirmed its “Outperform” rating on Agilent with a $153 price target; prior to the earnings release, the market had forecast Q2 EPS of $1.40 and revenue of about $1.8 billion.

The company also declared a quarterly dividend of $0.255 per share and named Tim Downs as its new Chief Accounting Officer, reflecting changes in its dividend policy and corporate governance.

Headquartered in California, Agilent supplies analytical and clinical laboratory instruments, consumables, and software. The company was spun off from Hewlett-Packard in 1999.

For fiscal 2025, Agilent expects revenue of about $6.95 billion (roughly KRW 9 trillion) and employs approximately 18,000 people worldwide, positioning it as a leading healthcare equipment company.